The aim of this study is to determine the significance of PI3K/Akt activation in ovarian cancer by examining Akt expression in tumor specimens, and the effects of PI3K/Akt inhibition using three AZD compounds, namely, AZD5363, AZD8835, and AZD8186 which are small molecule drugs. This evidence concerns the gene PIK3CA and neoplasm.